Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
Zhi Peng(Peking University), Lin Shen(Peking University), Liangming Zhang(Sun Yat-sen University), Chunmei Bai(Shanxi Medical University), Yuehong Cui, Jianmin Fang(Tongji University), Yi Ba(Tianjin Medical University Cancer Institute and Hospital), Jia Wei(North Sichuan Medical University), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongqian Shu(Jiangsu Cancer Hospital), Airong Wang(Fujian Agriculture and Forestry University), Jianwei Lu(Nantong Tumor Hospital), Jiangzheng Zeng(Hainan General Hospital), Shengmian Li(Hebei Medical University), Liuzhong Yang(First Affiliated Hospital of Xinxiang Medical University), Zhen Li(Linyi People's Hospital), Suxia Luo(Zhengzhou University), Tianshu Liu(Sun Yat-sen University), Ting Deng(Tianjin Medical University Cancer Institute and Hospital), Yong Liu(Army Medical University), Xinjun Liang(Hubei Provincial Center for Disease Control and Prevention), Jianming Xu(Chinese PLA General Hospital), Kangsheng Gu(Anhui Medical University), Guohua Yu(Weifang People's Hospital), Qingxia Fan(First Affiliated Hospital of Zhengzhou University), Rui‐Hua Xu(Sun Yat-sen University), Guanghai Dai(Chinese PLA General Hospital), Chao Gao(Qingdao University), Yifu He(Anhui Provincial Hospital), Yuping Sun(Henan Academy of Agricultural Sciences), Nanfeng Fan(Fujian Medical University), Nong Xu(First Affiliated Hospital Zhejiang University), Dong Ma(Guangdong Provincial People's Hospital), Xizhi Zhang(People's Hospital of Kaizhou District), Enxiao Li(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 207
Related Papers
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k